Consequences of a single short lasting cerebral oligemia and the influence of iron injected into the substantia nigra or in the ventrolateral striatum of the rat. Trigger of Parkinson’s disease pathogenesis? C. HeimT. A. SontagK.-H. Sontag OriginalPaper 02 April 2004 Pages: 641 - 666
Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol W. UkaiH. OzawaT. Saito OriginalPaper 02 April 2004 Pages: 667 - 681
CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome W. JordanC. BergerS. Bleich Short Communication Pages: 683 - 689
Pioneers of movement disorders: Georges Gilles de la Tourette H. KrämerC. Daniels Mini Review 19 March 2004 Pages: 691 - 701
Motor excitability and motor behaviour after modafinil ingestion – a double-blind placebo-controlled cross-over trial J. LiepertJ. Allstadt-SchmitzC. Weiller OriginalPaper 17 February 2004 Pages: 703 - 711
Novel dopamine releasing response of an anti-convulsant agent with possible anti-Parkinson’s activity M. R. GluckL. A. SantanaM. D. Yahr OriginalPaper 08 April 2004 Pages: 713 - 724
Usefulness of switching to cabergoline from other dopamine agonists in patients with advanced Parkinson’s disease M. ShiraishiT. KamoS. Shimojo OriginalPaper 19 March 2004 Pages: 725 - 732
Intronic polymorphism of tryptophan hydroxylase and serotonin transporter: indication for combined effect in predisposition to suicide B. JernejJ. StefuljM. Kubat OriginalPaper 17 February 2004 Pages: 733 - 738
Elevated triiodothyronine in psychopathy – possible physiological mechanisms H. SoderstromA. Forsman Short Communication 08 April 2004 Pages: 739 - 744